Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_assertion type Assertion NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_head.
- NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_assertion wasGeneratedBy ECO_0000203 NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_provenance.
- NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_assertion wasDerivedFrom befree-20150227 NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_provenance.
- NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_assertion SIO_000772 11034589 NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_provenance.
- NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_assertion evidence source_evidence_literature NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_provenance.
- NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_provenance.